News Maravai LifeSciences Holdings, Inc.

Equities

MRVI

US56600D1072

Market Closed - Nasdaq Other stock markets 16:00:00 2024-04-29 EDT			5-day change	1st Jan Change
7.85 ^USD	+1.95%		+6.51%	+19.85%

04-18	Maravai LifeSciences Unit Opens New Manufacturing Facility in San Diego	MT
04-10	Craig-Hallum Initiates Coverage on Maravai LifeSciences With Buy Rating, $15 Price Target	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

TriLink BioTechnologies Announces New San Diego Facility for Late Phase mRNA Drug Substance Production	04-19	AQ
Maravai LifeSciences Unit Opens New Manufacturing Facility in San Diego	04-18	MT
TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production	04-18	BU
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024	04-10	GL
Craig-Hallum Initiates Coverage on Maravai LifeSciences With Buy Rating, $15 Price Target	04-10	MT
RBC Raises Price Target on Maravai LifeSciences Holdings to $15 From $14, Keeps Outperform Rating	04-08	MT
Dyadic International Inc. (NASDAQ: DYAI) Funding to Propel Near-Term Revenue Growth Initiatives Highlights in Zacks Small-Cap Research Report	04-04	AQ
Transcript : Maravai LifeSciences Holdings, Inc. Presents at KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum, Mar-19-2024 02:15 PM	03-19
Maravai LifeSciences Announces March 2024 Investor Conference Schedule	03-12	GL
Recent Market Movers: Healthcare Companies Making Headlines: DYAI, RIGL, ARDX, VERO, MEDS	02-28	AQ
Healthcare Undervalued Opportunities Poised for Growth: DYAI, INBS, VTAK, RSCI, VERO, MRVI	02-27	AQ
Sector Update: Health Care Stocks Rise in Late Afternoon	02-23	MT
Sector Update: Health Care Stocks Advance Friday Afternoon	02-23	MT
Top Midday Gainers	02-23	MT
Sector Update: Health Care	02-23	MT
Maravai LifeSciences Shares Surge After Price Target Raises, Q4 Beat	02-23	MT
UBS Adjusts Maravai LifeSciences Price Target to $6.50 From $6, Maintains Neutral Rating	02-23	MT
Stifel Trims Price Target on Maravai LifeSciences to $10 From $11, Maintains Buy Rating	02-23	MT
Traders Await Fresh Cues After Nvidia-Fueled Rally as US Equity Futures Inch Higher Pre-Bell	02-23	MT
Sector Update: Health Care Stocks Mixed Premarket Friday	02-23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Maravai LifeSciences Holdings, Inc.

Equities

MRVI

US56600D1072

Summary

Filters